Substance Misuse: Substitution drugs (methadone and buprenorphine)

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Drug treatment services remain dominated by substitute prescribing programs for heroin (diacetylmorphine) dependent individuals. It is estimated that there are 15.6 million users of illicit opioids worldwide (WHO, 2009). North America as well as most European countries have some form of methadone or buprenorphine treatment for opioid dependence and depending on the size and history of the problem; a small or large percentage of the opioid dependent population will be in treatment. Basic pharmacokinetic, risk of overdose and measurement of methadone and buprenorphine in clinical settings will be discussed.
Original languageEnglish
Title of host publicationEncyclopaedia of Forensic and Legal Medicine
EditorsJason Payne-James, Roger W. Byard, Tracey S. Corey, Carol Henderson
Place of PublicationOxford, UK
PublisherElsevier
Pages436-441
Number of pages6
Edition2nd
Publication statusPublished - 2016

Fingerprint

Dive into the research topics of 'Substance Misuse: Substitution drugs (methadone and buprenorphine)'. Together they form a unique fingerprint.

Cite this